Zura Bio Ltd., a clinical-stage immunology company, is set to participate in the Cantor Fitzgerald Global Healthcare Conference in New York on September 4, 2025. The company's senior leadership team will present a fireside chat and conduct one-on-one investor meetings. A live webcast of the presentation will be accessible on the company's website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zura Bio Ltd. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250820026356) on August 20, 2025, and is solely responsible for the information contained therein.
Comments